FDA Approves Zurampic to Treat High Blood Uric Acid Levels Associated with Gout

Molecular and Cellular Pharmacology, Vol 7, No 3 (2015)

FDA Approves Zurampic to Treat High Blood Uric Acid Levels Associated with Gout

FDA News Release

Abstract

The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric acid in the body. ….(click PDF to read more)

Full Text: PDF

LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041